Hereditary Angioedema Drug-Global Market Status and Trend Report 2013-2023
Report Summary
Hereditary Angioedema Drug-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Hereditary Angioedema Drug industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Hereditary Angioedema Drug 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Hereditary Angioedema Drug worldwide, with company and product introduction, position in the Hereditary Angioedema Drug market
Market status and development trend of Hereditary Angioedema Drug by types and applications
Cost and profit status of Hereditary Angioedema Drug, and marketing status
Market growth drivers and challenges
The report segments the global Hereditary Angioedema Drug market as:
Global Hereditary Angioedema Drug Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Hereditary Angioedema Drug Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
By Product
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
By Route of Administration
Oral
Intravenous
Subcutaneous Injection
Global Hereditary Angioedema Drug Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Global Hereditary Angioedema Drug Market: Manufacturers Segment Analysis (Company and Product introduction, Hereditary Angioedema Drug Sales Volume, Revenue, Price and Gross Margin):
Pharming Group NV
Shire plc
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Hereditary Angioedema Drug-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Hereditary Angioedema Drug industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Hereditary Angioedema Drug 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Hereditary Angioedema Drug worldwide, with company and product introduction, position in the Hereditary Angioedema Drug market
Market status and development trend of Hereditary Angioedema Drug by types and applications
Cost and profit status of Hereditary Angioedema Drug, and marketing status
Market growth drivers and challenges
The report segments the global Hereditary Angioedema Drug market as:
Global Hereditary Angioedema Drug Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Hereditary Angioedema Drug Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
By Product
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
By Route of Administration
Oral
Intravenous
Subcutaneous Injection
Global Hereditary Angioedema Drug Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Global Hereditary Angioedema Drug Market: Manufacturers Segment Analysis (Company and Product introduction, Hereditary Angioedema Drug Sales Volume, Revenue, Price and Gross Margin):
Pharming Group NV
Shire plc
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF HEREDITARY ANGIOEDEMA DRUG
1.1 Definition of Hereditary Angioedema Drug in This Report
1.2 Commercial Types of Hereditary Angioedema Drug
1.2.1 By Product
1.2.2 C1 Esterase Inhibitor
1.2.3 Kallikrein Inhibitor
1.2.4 Selective Bradykinin B2 Receptor Antagonist
1.2.5 By Route of Administration
1.2.6 Oral
1.2.7 Intravenous
1.2.8 Subcutaneous Injection
1.3 Downstream Application of Hereditary Angioedema Drug
1.3.1 Retail Pharmacies
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.4 Development History of Hereditary Angioedema Drug
1.5 Market Status and Trend of Hereditary Angioedema Drug 2013-2023
1.5.1 Global Hereditary Angioedema Drug Market Status and Trend 2013-2023
1.5.2 Regional Hereditary Angioedema Drug Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Hereditary Angioedema Drug 2013-2017
2.2 Production Market of Hereditary Angioedema Drug by Regions
2.2.1 Production Volume of Hereditary Angioedema Drug by Regions
2.2.2 Production Value of Hereditary Angioedema Drug by Regions
2.3 Demand Market of Hereditary Angioedema Drug by Regions
2.4 Production and Demand Status of Hereditary Angioedema Drug by Regions
2.4.1 Production and Demand Status of Hereditary Angioedema Drug by Regions 2013-2017
2.4.2 Import and Export Status of Hereditary Angioedema Drug by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Hereditary Angioedema Drug by Types
3.2 Production Value of Hereditary Angioedema Drug by Types
3.3 Market Forecast of Hereditary Angioedema Drug by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Hereditary Angioedema Drug by Downstream Industry
4.2 Market Forecast of Hereditary Angioedema Drug by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF HEREDITARY ANGIOEDEMA DRUG
5.1 Global Economy Situation and Trend Overview
5.2 Hereditary Angioedema Drug Downstream Industry Situation and Trend Overview
CHAPTER 6 HEREDITARY ANGIOEDEMA DRUG MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Hereditary Angioedema Drug by Major Manufacturers
6.2 Production Value of Hereditary Angioedema Drug by Major Manufacturers
6.3 Basic Information of Hereditary Angioedema Drug by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Hereditary Angioedema Drug Major Manufacturer
6.3.2 Employees and Revenue Level of Hereditary Angioedema Drug Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 HEREDITARY ANGIOEDEMA DRUG MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Pharming Group NV
7.1.1 Company profile
7.1.2 Representative Hereditary Angioedema Drug Product
7.1.3 Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin of Pharming Group NV
7.2 Shire plc
7.2.1 Company profile
7.2.2 Representative Hereditary Angioedema Drug Product
7.2.3 Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin of Shire plc
7.3 CSL Limited
7.3.1 Company profile
7.3.2 Representative Hereditary Angioedema Drug Product
7.3.3 Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin of CSL Limited
7.4 iBio Inc.
7.4.1 Company profile
7.4.2 Representative Hereditary Angioedema Drug Product
7.4.3 Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin of iBio Inc.
7.5 BioCryst Pharmaceuticals, Inc.
7.5.1 Company profile
7.5.2 Representative Hereditary Angioedema Drug Product
7.5.3 Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin of BioCryst Pharmaceuticals, Inc.
7.6 Ionis Pharmaceuticals, Inc.
7.6.1 Company profile
7.6.2 Representative Hereditary Angioedema Drug Product
7.6.3 Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin of Ionis Pharmaceuticals, Inc.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF HEREDITARY ANGIOEDEMA DRUG
8.1 Industry Chain of Hereditary Angioedema Drug
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF HEREDITARY ANGIOEDEMA DRUG
9.1 Cost Structure Analysis of Hereditary Angioedema Drug
9.2 Raw Materials Cost Analysis of Hereditary Angioedema Drug
9.3 Labor Cost Analysis of Hereditary Angioedema Drug
9.4 Manufacturing Expenses Analysis of Hereditary Angioedema Drug
CHAPTER 10 MARKETING STATUS ANALYSIS OF HEREDITARY ANGIOEDEMA DRUG
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Hereditary Angioedema Drug in This Report
1.2 Commercial Types of Hereditary Angioedema Drug
1.2.1 By Product
1.2.2 C1 Esterase Inhibitor
1.2.3 Kallikrein Inhibitor
1.2.4 Selective Bradykinin B2 Receptor Antagonist
1.2.5 By Route of Administration
1.2.6 Oral
1.2.7 Intravenous
1.2.8 Subcutaneous Injection
1.3 Downstream Application of Hereditary Angioedema Drug
1.3.1 Retail Pharmacies
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.4 Development History of Hereditary Angioedema Drug
1.5 Market Status and Trend of Hereditary Angioedema Drug 2013-2023
1.5.1 Global Hereditary Angioedema Drug Market Status and Trend 2013-2023
1.5.2 Regional Hereditary Angioedema Drug Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Hereditary Angioedema Drug 2013-2017
2.2 Production Market of Hereditary Angioedema Drug by Regions
2.2.1 Production Volume of Hereditary Angioedema Drug by Regions
2.2.2 Production Value of Hereditary Angioedema Drug by Regions
2.3 Demand Market of Hereditary Angioedema Drug by Regions
2.4 Production and Demand Status of Hereditary Angioedema Drug by Regions
2.4.1 Production and Demand Status of Hereditary Angioedema Drug by Regions 2013-2017
2.4.2 Import and Export Status of Hereditary Angioedema Drug by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Hereditary Angioedema Drug by Types
3.2 Production Value of Hereditary Angioedema Drug by Types
3.3 Market Forecast of Hereditary Angioedema Drug by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Hereditary Angioedema Drug by Downstream Industry
4.2 Market Forecast of Hereditary Angioedema Drug by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF HEREDITARY ANGIOEDEMA DRUG
5.1 Global Economy Situation and Trend Overview
5.2 Hereditary Angioedema Drug Downstream Industry Situation and Trend Overview
CHAPTER 6 HEREDITARY ANGIOEDEMA DRUG MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Hereditary Angioedema Drug by Major Manufacturers
6.2 Production Value of Hereditary Angioedema Drug by Major Manufacturers
6.3 Basic Information of Hereditary Angioedema Drug by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Hereditary Angioedema Drug Major Manufacturer
6.3.2 Employees and Revenue Level of Hereditary Angioedema Drug Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 HEREDITARY ANGIOEDEMA DRUG MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Pharming Group NV
7.1.1 Company profile
7.1.2 Representative Hereditary Angioedema Drug Product
7.1.3 Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin of Pharming Group NV
7.2 Shire plc
7.2.1 Company profile
7.2.2 Representative Hereditary Angioedema Drug Product
7.2.3 Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin of Shire plc
7.3 CSL Limited
7.3.1 Company profile
7.3.2 Representative Hereditary Angioedema Drug Product
7.3.3 Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin of CSL Limited
7.4 iBio Inc.
7.4.1 Company profile
7.4.2 Representative Hereditary Angioedema Drug Product
7.4.3 Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin of iBio Inc.
7.5 BioCryst Pharmaceuticals, Inc.
7.5.1 Company profile
7.5.2 Representative Hereditary Angioedema Drug Product
7.5.3 Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin of BioCryst Pharmaceuticals, Inc.
7.6 Ionis Pharmaceuticals, Inc.
7.6.1 Company profile
7.6.2 Representative Hereditary Angioedema Drug Product
7.6.3 Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin of Ionis Pharmaceuticals, Inc.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF HEREDITARY ANGIOEDEMA DRUG
8.1 Industry Chain of Hereditary Angioedema Drug
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF HEREDITARY ANGIOEDEMA DRUG
9.1 Cost Structure Analysis of Hereditary Angioedema Drug
9.2 Raw Materials Cost Analysis of Hereditary Angioedema Drug
9.3 Labor Cost Analysis of Hereditary Angioedema Drug
9.4 Manufacturing Expenses Analysis of Hereditary Angioedema Drug
CHAPTER 10 MARKETING STATUS ANALYSIS OF HEREDITARY ANGIOEDEMA DRUG
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
